Anticancer Hybrids- A Patent Survey

Publisher： Bentham Science Publishers

E-ISSN： 2212-3970|9|3|303-339

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.9, Iss.3, 2014-09, pp. : 303-339

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tubulin Inhibitors: A Patent Survey

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Iss. 2, 2014-05 ,pp. : 176-220

Bentham Science Publishers

Access to resources Recommend Favorite

Novel N-mustard-benzimidazoles/benzothiazoles Hybrids, Synthesis and Anticancer Evaluation

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 13, 2018-01 ,pp. : 1741-1755

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs)

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 109-141

Bentham Science Publishers

Access to resources Recommend Favorite

The Ubiquitin-Proteasome Pathway an Emerging Anticancer Strategy for Therapeutics: A Patent Analysis

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 2, 2015-05 ,pp. : 201-213

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Cancer Pyrimidines in Diverse Scaffolds: A Review of Patent Literature

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 1, 2014-12 ,pp. : 23-71

Bentham Science Publishers

Access to resources Recommend Favorite